Prevalence and Prognosis of Hyperkalemia in Patients with Acute Myocardial Infarction

Abstract Background Hyperkalemia is common and potentially dangerous in hospitalized patients; its contemporary prevalence and prognostic importance after acute myocardial infarction are not well described. Methods In 38,689 consecutive patients with acute myocardial infarction from the Cerner Healt...

Full description

Saved in:
Bibliographic Details
Published inThe American journal of medicine Vol. 129; no. 8; pp. 858 - 865
Main Authors Grodzinsky, Anna, MD, MSc, Goyal, Abhinav, MD, MHS, Gosch, Kensey, MS, McCullough, Peter A., MD, MPH, Fonarow, Gregg C., MD, Mebazaa, Alexandre, MD, Masoudi, Frederick A., MD, MSPH, Spertus, John A., MD, MPH, Palmer, Biff F., MD, Kosiborod, Mikhail, MD
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.08.2016
Elsevier Sequoia S.A
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Abstract Background Hyperkalemia is common and potentially dangerous in hospitalized patients; its contemporary prevalence and prognostic importance after acute myocardial infarction are not well described. Methods In 38,689 consecutive patients with acute myocardial infarction from the Cerner Health Facts database, we evaluated the association between maximum in-hospital potassium levels and in-hospital mortality. Patients were stratified by dialysis status and grouped by maximum potassium as follows: <5 mEq/L, 5 to <5.5 mEq/L, 5.5 to <6.0 mEq/L, 6.0 to <6.5 mEq/L, and ≥6.5 mEq/L. Multivariable logistic regression was used to adjust for multiple patient and site characteristics. The relationship between the number of hyperkalemic values and the in-hospital mortality was evaluated. Results Of 38,689 patients with acute myocardial infarction, 886 were on dialysis. The rate of hyperkalemia (maximum potassium ≥5.0 mEq/L) was 22.6% in patients on dialysis and 66.8% in patients not on dialysis. Moderate to severe hyperkalemia (maximum potassium ≥5.5 mEq/L) occurred in 9.8% of patients. There was a steep increase in mortality with higher maximum potassium levels. In-hospital mortality exceeded 15% once maximum potassium was ≥5.5 mEq/L regardless of dialysis status. The relationship between higher maximum potassium and increased mortality risk persisted after multivariable adjustment. In addition, patients with a greater number of hyperkalemic values (vs a single value) experienced higher in-hospital mortality. Conclusions Hyperkalemia is common in patients who are hospitalized with acute myocardial infarction. Higher maximum potassium levels and number of hyperkalemic events are associated with a steep mortality increase, with higher risks for adverse outcomes observed even at mild levels of hyperkalemia. Whether more intensive management of hyperkalemia may improve outcomes in patients with acute myocardial infarction merits further study.
AbstractList BACKGROUNDHyperkalemia is common and potentially dangerous in hospitalized patients; its contemporary prevalence and prognostic importance after acute myocardial infarction are not well described.METHODSIn 38,689 consecutive patients with acute myocardial infarction from the Cerner Health Facts database, we evaluated the association between maximum in-hospital potassium levels and in-hospital mortality. Patients were stratified by dialysis status and grouped by maximum potassium as follows: <5 mEq/L, 5 to <5.5 mEq/L, 5.5 to <6.0 mEq/L, 6.0 to <6.5 mEq/L, and ≥6.5 mEq/L. Multivariable logistic regression was used to adjust for multiple patient and site characteristics. The relationship between the number of hyperkalemic values and the in-hospital mortality was evaluated.RESULTSOf 38,689 patients with acute myocardial infarction, 886 were on dialysis. The rate of hyperkalemia (maximum potassium ≥5.0 mEq/L) was 22.6% in patients on dialysis and 66.8% in patients not on dialysis. Moderate to severe hyperkalemia (maximum potassium ≥5.5 mEq/L) occurred in 9.8% of patients. There was a steep increase in mortality with higher maximum potassium levels. In-hospital mortality exceeded 15% once maximum potassium was ≥5.5 mEq/L regardless of dialysis status. The relationship between higher maximum potassium and increased mortality risk persisted after multivariable adjustment. In addition, patients with a greater number of hyperkalemic values (vs a single value) experienced higher in-hospital mortality.CONCLUSIONSHyperkalemia is common in patients who are hospitalized with acute myocardial infarction. Higher maximum potassium levels and number of hyperkalemic events are associated with a steep mortality increase, with higher risks for adverse outcomes observed even at mild levels of hyperkalemia. Whether more intensive management of hyperkalemia may improve outcomes in patients with acute myocardial infarction merits further study.
Abstract Background Hyperkalemia is common and potentially dangerous in hospitalized patients; its contemporary prevalence and prognostic importance after acute myocardial infarction are not well described. Methods In 38,689 consecutive patients with acute myocardial infarction from the Cerner Health Facts database, we evaluated the association between maximum in-hospital potassium levels and in-hospital mortality. Patients were stratified by dialysis status and grouped by maximum potassium as follows: <5 mEq/L, 5 to <5.5 mEq/L, 5.5 to <6.0 mEq/L, 6.0 to <6.5 mEq/L, and ≥6.5 mEq/L. Multivariable logistic regression was used to adjust for multiple patient and site characteristics. The relationship between the number of hyperkalemic values and the in-hospital mortality was evaluated. Results Of 38,689 patients with acute myocardial infarction, 886 were on dialysis. The rate of hyperkalemia (maximum potassium ≥5.0 mEq/L) was 22.6% in patients on dialysis and 66.8% in patients not on dialysis. Moderate to severe hyperkalemia (maximum potassium ≥5.5 mEq/L) occurred in 9.8% of patients. There was a steep increase in mortality with higher maximum potassium levels. In-hospital mortality exceeded 15% once maximum potassium was ≥5.5 mEq/L regardless of dialysis status. The relationship between higher maximum potassium and increased mortality risk persisted after multivariable adjustment. In addition, patients with a greater number of hyperkalemic values (vs a single value) experienced higher in-hospital mortality. Conclusions Hyperkalemia is common in patients who are hospitalized with acute myocardial infarction. Higher maximum potassium levels and number of hyperkalemic events are associated with a steep mortality increase, with higher risks for adverse outcomes observed even at mild levels of hyperkalemia. Whether more intensive management of hyperkalemia may improve outcomes in patients with acute myocardial infarction merits further study.
Grodzinsky et al determine the contemporary prevalence and prognostic importance of hyperkalemia after acute myocardial infarction. Of 38,689 patients with acute myocardial infarction, 886 were on dialysis. The rate of hyperkalemia (maximum potassium ≥5.0 mEq/L) was 22.6% in patients on dialysis and 66.8% in patients not on dialysis. Moderate to severe hyperkalemia (maximum potassium ≥5.5 mEq/L) occurred in 9.8% of patients. There was a steep increase in mortality with higher maximum potassium levels. In-hospital mortality exceeded 15% once maximum potassium was ≥5.5 mEq/L regardless of dialysis status. The relationship between higher maximum potassium and increased mortality risk persisted after multivariable adjustment. In addition, patients with a greater number of hyperkalemic values (vs a single value) experienced higher in-hospital mortality.
Hyperkalemia is common and potentially dangerous in hospitalized patients; its contemporary prevalence and prognostic importance after acute myocardial infarction are not well described. In 38,689 consecutive patients with acute myocardial infarction from the Cerner Health Facts database, we evaluated the association between maximum in-hospital potassium levels and in-hospital mortality. Patients were stratified by dialysis status and grouped by maximum potassium as follows: <5 mEq/L, 5 to <5.5 mEq/L, 5.5 to <6.0 mEq/L, 6.0 to <6.5 mEq/L, and ≥6.5 mEq/L. Multivariable logistic regression was used to adjust for multiple patient and site characteristics. The relationship between the number of hyperkalemic values and the in-hospital mortality was evaluated. Of 38,689 patients with acute myocardial infarction, 886 were on dialysis. The rate of hyperkalemia (maximum potassium ≥5.0 mEq/L) was 22.6% in patients on dialysis and 66.8% in patients not on dialysis. Moderate to severe hyperkalemia (maximum potassium ≥5.5 mEq/L) occurred in 9.8% of patients. There was a steep increase in mortality with higher maximum potassium levels. In-hospital mortality exceeded 15% once maximum potassium was ≥5.5 mEq/L regardless of dialysis status. The relationship between higher maximum potassium and increased mortality risk persisted after multivariable adjustment. In addition, patients with a greater number of hyperkalemic values (vs a single value) experienced higher in-hospital mortality. Hyperkalemia is common in patients who are hospitalized with acute myocardial infarction. Higher maximum potassium levels and number of hyperkalemic events are associated with a steep mortality increase, with higher risks for adverse outcomes observed even at mild levels of hyperkalemia. Whether more intensive management of hyperkalemia may improve outcomes in patients with acute myocardial infarction merits further study.
Author Fonarow, Gregg C., MD
Gosch, Kensey, MS
Grodzinsky, Anna, MD, MSc
Mebazaa, Alexandre, MD
Kosiborod, Mikhail, MD
Masoudi, Frederick A., MD, MSPH
Goyal, Abhinav, MD, MHS
Palmer, Biff F., MD
Spertus, John A., MD, MPH
McCullough, Peter A., MD, MPH
AuthorAffiliation 6 Division of Nephrology, University of Texas Southwestern Medical Center
3 Division of Cardiology, Emory Healthcare, and Emory School of Medicine, Atlanta, GA
5 Division of Cardiology, University of California-Los Angeles, Los Angeles, CA
1 Saint Luke’s Mid America Heart Institute, Kansas City, MO
7 Division of Cardiology, University of Colorado Anschutz Medical Campus, Aurora, CO
8 Department of Anesthesia and Critical Care Medicine, Hôpitaux Universitaire, Saint Louis Lariboisière; U-942 Inserm; University Paris Diderot, Sorbonne Paris Cité, Paris, France
2 University of Missouri-Kansas City, Kansas City, MO
4 Baylor University Medical Center, Baylor Heart and Vascular Institute, Baylor Jack and Jane Hamilton Heart and Vascular Hospital, Dallas, TX, The Heart Hospital, Plano, TX
AuthorAffiliation_xml – name: 5 Division of Cardiology, University of California-Los Angeles, Los Angeles, CA
– name: 3 Division of Cardiology, Emory Healthcare, and Emory School of Medicine, Atlanta, GA
– name: 6 Division of Nephrology, University of Texas Southwestern Medical Center
– name: 1 Saint Luke’s Mid America Heart Institute, Kansas City, MO
– name: 4 Baylor University Medical Center, Baylor Heart and Vascular Institute, Baylor Jack and Jane Hamilton Heart and Vascular Hospital, Dallas, TX, The Heart Hospital, Plano, TX
– name: 7 Division of Cardiology, University of Colorado Anschutz Medical Campus, Aurora, CO
– name: 2 University of Missouri-Kansas City, Kansas City, MO
– name: 8 Department of Anesthesia and Critical Care Medicine, Hôpitaux Universitaire, Saint Louis Lariboisière; U-942 Inserm; University Paris Diderot, Sorbonne Paris Cité, Paris, France
Author_xml – sequence: 1
  fullname: Grodzinsky, Anna, MD, MSc
– sequence: 2
  fullname: Goyal, Abhinav, MD, MHS
– sequence: 3
  fullname: Gosch, Kensey, MS
– sequence: 4
  fullname: McCullough, Peter A., MD, MPH
– sequence: 5
  fullname: Fonarow, Gregg C., MD
– sequence: 6
  fullname: Mebazaa, Alexandre, MD
– sequence: 7
  fullname: Masoudi, Frederick A., MD, MSPH
– sequence: 8
  fullname: Spertus, John A., MD, MPH
– sequence: 9
  fullname: Palmer, Biff F., MD
– sequence: 10
  fullname: Kosiborod, Mikhail, MD
BackLink https://www.ncbi.nlm.nih.gov/pubmed/27060233$$D View this record in MEDLINE/PubMed
BookMark eNqFUk1v1DAQtVAR3Rb-AUKWuHBJGH8k2VyQqqrQSkWsBD1bXnvSOk3sxc4u2n-Poy0t9MLBsqx58zzvvTkhRz54JOQtg5IBqz_2pR77EW3J86sEUQIsX5AFq6qqaFjNj8gCAHjRCimOyUlKfX5CW9WvyDFvoAYuxILcrCLu9IDeINXe0lUMtz4kl2jo6OV-g_E-V0enqfN0pSeHfkr0l5vu6JnZTki_7oPR0To90Cvf6WgmF_xr8rLTQ8I3D_cpufl88eP8srj-9uXq_Oy6MJWsp0JazdYSrW2ZWHfMInRdxxvJAY0xHEDarq216SQ069YIwbXW1tQgcSm0leKUfDrwbrbrbIXJw0U9qE10o457FbRT_1a8u1O3YacqECw7lQk-PBDE8HOLaVKjSwaHQXsM26TYEhrIh9UZ-v4ZtA_b6LO8jGLLBiRUIqPkAWViSCli9zgMAzXnpnp1yE3NuSkQKueW2979LeSx6U9QT0ox27lzGFUybk7NuohmUja4__3wnMAMzjujh3vcY3rSohJXoL7PuzOvTlaevWoq8Rs708Nn
CODEN AJMEAZ
CitedBy_id crossref_primary_10_1097_PCC_0000000000002391
crossref_primary_10_1097_PCC_0000000000002351
crossref_primary_10_1055_s_0040_1719172
crossref_primary_10_1016_j_mayocp_2020_06_014
crossref_primary_10_1186_s12937_023_00888_z
crossref_primary_10_1080_14656566_2020_1810234
crossref_primary_10_1177_2047487318780466
crossref_primary_10_1080_14656566_2021_1891223
crossref_primary_10_1093_bja_aex163
crossref_primary_10_7759_cureus_10401
crossref_primary_10_1001_jamanetworkopen_2021_38420
crossref_primary_10_1093_ndt_gfy249
crossref_primary_10_1080_0886022X_2023_2212800
crossref_primary_10_1080_21548331_2021_1925554
crossref_primary_10_3389_fcvm_2023_1129235
crossref_primary_10_5863_1551_6776_27_4_358
crossref_primary_10_1016_j_bbrc_2018_04_026
crossref_primary_10_1177_2047487318759694
crossref_primary_10_1681_ASN_2016121344
crossref_primary_10_1016_j_medcli_2017_03_013
crossref_primary_10_1016_j_ijcard_2020_08_044
crossref_primary_10_1053_j_ajkd_2021_07_008
crossref_primary_10_1097_CCM_0000000000003521
crossref_primary_10_1161_JAHA_118_011814
crossref_primary_10_1016_j_medcle_2017_03_014
crossref_primary_10_15441_ceem_16_194
crossref_primary_10_1016_j_cjco_2023_10_011
crossref_primary_10_1016_j_ajem_2021_02_005
crossref_primary_10_1016_j_jemermed_2018_09_007
crossref_primary_10_15441_ceem_17_207
Cites_doi 10.3909/ricm0727
10.1016/j.jacc.2014.05.040
10.1161/CIRCULATIONAHA.108.778811
10.1001/jama.2014.15688
10.1590/S0066-782X2008000300004
10.1056/NEJMoa1410853
10.1161/CIRCULATIONAHA.104.492348
10.1097/MAJ.0b013e318279b105
10.1186/cc11872
10.1016/S0002-9343(00)00496-4
10.1007/s00134-012-2636-7
10.1016/j.ccc.2004.12.003
10.1016/0002-9149(85)91110-5
10.1161/hc4101.096153
10.1056/NEJMoa1411487
10.1001/jama.2011.1967
10.1056/NEJMoa040135
10.2215/CJN.01970310
ContentType Journal Article
Copyright Elsevier Inc.
2016 Elsevier Inc.
Copyright © 2016 Elsevier Inc. All rights reserved.
Copyright Elsevier Science Ltd. Aug 2016
Copyright_xml – notice: Elsevier Inc.
– notice: 2016 Elsevier Inc.
– notice: Copyright © 2016 Elsevier Inc. All rights reserved.
– notice: Copyright Elsevier Science Ltd. Aug 2016
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7T5
7TK
7TO
7TS
7U9
H94
K9.
7X8
5PM
DOI 10.1016/j.amjmed.2016.03.008
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
Immunology Abstracts
Neurosciences Abstracts
Oncogenes and Growth Factors Abstracts
Physical Education Index
Virology and AIDS Abstracts
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
Virology and AIDS Abstracts
Oncogenes and Growth Factors Abstracts
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Immunology Abstracts
Neurosciences Abstracts
Physical Education Index
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic

Virology and AIDS Abstracts

MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1555-7162
EndPage 865
ExternalDocumentID 4179725011
10_1016_j_amjmed_2016_03_008
27060233
S0002934316303175
1_s2_0_S0002934316303175
Genre Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: National Heart, Lung, and Blood Institute
  grantid: T32HL110837
  funderid: http://dx.doi.org/10.13039/100000050
– fundername: NHLBI NIH HHS
  grantid: T32 HL110837
GroupedDBID ---
--K
-~X
.-4
.1-
.55
.FO
.GJ
0R~
0SF
123
1B1
1CY
1P~
1RT
1~5
23M
3O-
4.4
457
4CK
4G.
53G
5RE
5VS
6J9
7-5
AACTN
AAEDT
AAEDW
AALRI
AAQFI
AAQQT
AAQXK
AAWTL
AAXUO
AAYOK
ABLJU
ABMAC
ABOCM
ABPPZ
ACGFO
ACIUM
ACKOT
ACPRK
ADBBV
ADMUD
ADPAM
ADVLN
AENEX
AEVXI
AFCTW
AFFNX
AFHKK
AFJKZ
AFRHN
AFTJW
AGHFR
AHHHB
AHMBA
AITUG
AJUYK
AKRWK
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ASPBG
AVWKF
AZFZN
BELOY
BKOMP
C5W
CS3
EBS
EFJIC
EJD
EX3
F5P
FDB
FEDTE
FGOYB
FIRID
G-2
G-Q
GBLVA
HEA
HMK
HMO
HVGLF
HZ~
IH2
IHE
J1W
J5H
K-O
KOM
L7B
LZ2
M29
M41
MO0
MVM
N4W
N9A
NCXOZ
NQ-
O9-
OD.
OHT
OO~
P2P
PC.
PQQKQ
R2-
RIG
ROL
RPZ
SAE
SEL
SES
SSZ
TWZ
UBY
UHB
UHU
UNMZH
UV1
WH7
WOW
WUQ
X7M
XH2
XPP
YFH
YOC
YQJ
YYQ
Z5R
ZGI
ZUP
ZXP
AAIAV
AGZHU
AHPSJ
ALXNB
ZA5
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7T5
7TK
7TO
7TS
7U9
H94
K9.
7X8
5PM
ID FETCH-LOGICAL-c546t-4da1b4edd913bf1de0fff27420eccc2004df96acf407b9c332aaadc604e83ad43
ISSN 0002-9343
IngestDate Tue Sep 17 21:12:28 EDT 2024
Fri Aug 16 07:22:54 EDT 2024
Thu Oct 10 15:57:58 EDT 2024
Thu Sep 26 17:42:36 EDT 2024
Sat Sep 28 08:46:11 EDT 2024
Fri Feb 23 02:17:03 EST 2024
Tue Oct 15 14:37:25 EDT 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 8
Keywords Acute myocardial infarction
Hyperkalemia prevalence
Dialysis
Language English
License Copyright © 2016 Elsevier Inc. All rights reserved.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c546t-4da1b4edd913bf1de0fff27420eccc2004df96acf407b9c332aaadc604e83ad43
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://europepmc.org/articles/pmc5031155?pdf=render
PMID 27060233
PQID 1818704053
PQPubID 950
PageCount 8
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_5031155
proquest_miscellaneous_1807080716
proquest_journals_1818704053
crossref_primary_10_1016_j_amjmed_2016_03_008
pubmed_primary_27060233
elsevier_sciencedirect_doi_10_1016_j_amjmed_2016_03_008
elsevier_clinicalkeyesjournals_1_s2_0_S0002934316303175
PublicationCentury 2000
PublicationDate 2016-08-01
PublicationDateYYYYMMDD 2016-08-01
PublicationDate_xml – month: 08
  year: 2016
  text: 2016-08-01
  day: 01
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: New York
PublicationTitle The American journal of medicine
PublicationTitleAlternate Am J Med
PublicationYear 2016
Publisher Elsevier Inc
Elsevier Sequoia S.A
Publisher_xml – name: Elsevier Inc
– name: Elsevier Sequoia S.A
References An, Lee, Jeon (bib2) 2012; 16
McMahon, Mendu, Gibbons, Christopher (bib14) 2012; 38
Fordjour, Walton, Doran (bib10) 2014; 347
Wozakowska-Kaplon, Janowska-Molenda (bib8) 2009; 119
Nordrehaug (bib15) 1985; 56
McCullough, Beaver, Bennett-Guerrero (bib3) 2014; 15
Pitt, Bakris, Ruilope, DiCarlo, Mukherjee (bib6) 2008; 118
Schoolwerth, Sica, Ballermann, Wilcox (bib16) 2001; 104
Juurlink, Mamdani, Lee (bib7) 2004; 351
Goyal, Spertus, Gosch (bib1) 2012; 307
Moore, Bailey (bib17) 1989; 102
Garovic, Textor (bib12) 2005; 112
Salisbury, Reid, Marso (bib13) 2014; 64
US Department of Health and Human Services. National Diabetes Statistics Report: Estimates of Diabetes and Its Burden in the United States. Centers for Disease Control and Prevention. Available at
Kosiborod, Rasmussen, Lavin (bib20) 2014; 312
Perazella (bib9) 2000; 109
Lima, Ochiai, Cardoso, Morgado, Munhoz, Barretto (bib18) 2008; 91
Accessed May 1, 2015.
Weir, Bakris, Bushinsky (bib19) 2015; 372
Packham, Rasmussen, Lavin (bib21) 2015; 372
Weir, Juurlink, Gomes (bib5) 2010; 5
McCullough, Soman (bib11) 2005; 21
16129817 - Circulation. 2005 Aug 30;112(9):1362-74
15781162 - Crit Care Clin. 2005 Apr;21(2):261-80
23171442 - Crit Care. 2012 Nov 21;16(6):R225
22806439 - Intensive Care Med. 2012 Nov;38(11):1834-42
19514643 - Pol Arch Med Wewn. 2009 Mar;119(3):141-7
10996582 - Am J Med. 2000 Sep;109(4):307-14
4036815 - Am J Cardiol. 1985 Aug 30;56(6):20D-23D
20595693 - Clin J Am Soc Nephrol. 2010 Sep;5(9):1544-51
18824643 - Circulation. 2008 Oct 14;118(16):1643-50
15295047 - N Engl J Med. 2004 Aug 5;351(6):543-51
11602506 - Circulation. 2001 Oct 16;104(16):1985-91
25415807 - N Engl J Med. 2015 Jan 15;372(3):222-31
23255245 - Am J Med Sci. 2014 Feb;347(2):93-100
25145526 - J Am Coll Cardiol. 2014 Aug 26;64(8):811-9
18853060 - Arq Bras Cardiol. 2008 Sep;91(3):177-82, 194-9
24762462 - Rev Cardiovasc Med. 2014;15(1):11-23
25415805 - N Engl J Med. 2015 Jan 15;372(3):211-21
25402495 - JAMA. 2014 Dec 3;312(21):2223-33
2812582 - N Z Med J. 1989 Oct 25;102(878):557-8
22235086 - JAMA. 2012 Jan 11;307(2):157-64
Schoolwerth (10.1016/j.amjmed.2016.03.008_bib16) 2001; 104
Moore (10.1016/j.amjmed.2016.03.008_bib17) 1989; 102
McCullough (10.1016/j.amjmed.2016.03.008_bib3) 2014; 15
Juurlink (10.1016/j.amjmed.2016.03.008_bib7) 2004; 351
McCullough (10.1016/j.amjmed.2016.03.008_bib11) 2005; 21
Kosiborod (10.1016/j.amjmed.2016.03.008_bib20) 2014; 312
Packham (10.1016/j.amjmed.2016.03.008_bib21) 2015; 372
McMahon (10.1016/j.amjmed.2016.03.008_bib14) 2012; 38
Goyal (10.1016/j.amjmed.2016.03.008_bib1) 2012; 307
Pitt (10.1016/j.amjmed.2016.03.008_bib6) 2008; 118
Garovic (10.1016/j.amjmed.2016.03.008_bib12) 2005; 112
Weir (10.1016/j.amjmed.2016.03.008_bib5) 2010; 5
An (10.1016/j.amjmed.2016.03.008_bib2) 2012; 16
Wozakowska-Kaplon (10.1016/j.amjmed.2016.03.008_bib8) 2009; 119
Salisbury (10.1016/j.amjmed.2016.03.008_bib13) 2014; 64
Weir (10.1016/j.amjmed.2016.03.008_bib19) 2015; 372
Fordjour (10.1016/j.amjmed.2016.03.008_bib10) 2014; 347
Lima (10.1016/j.amjmed.2016.03.008_bib18) 2008; 91
Perazella (10.1016/j.amjmed.2016.03.008_bib9) 2000; 109
10.1016/j.amjmed.2016.03.008_bib4
Nordrehaug (10.1016/j.amjmed.2016.03.008_bib15) 1985; 56
References_xml – volume: 21
  start-page: 261
  year: 2005
  end-page: 280
  ident: bib11
  article-title: Contrast-induced nephropathy
  publication-title: Crit Care Clin
  contributor:
    fullname: Soman
– volume: 91
  start-page: 177
  year: 2008
  end-page: 182
  ident: bib18
  article-title: Hyperkalemia during spironolactone use in patients with decompensated heart failure
  publication-title: Arq Bras Cardiol
  contributor:
    fullname: Barretto
– volume: 118
  start-page: 1643
  year: 2008
  end-page: 1650
  ident: bib6
  article-title: Serum potassium and clinical outcomes in the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS)
  publication-title: Circulation
  contributor:
    fullname: Mukherjee
– volume: 102
  start-page: 557
  year: 1989
  end-page: 558
  ident: bib17
  article-title: Hyperkalaemia in patients in hospital
  publication-title: N Z Med J
  contributor:
    fullname: Bailey
– volume: 307
  start-page: 157
  year: 2012
  end-page: 164
  ident: bib1
  article-title: Serum potassium levels and mortality in acute myocardial infarction
  publication-title: JAMA
  contributor:
    fullname: Gosch
– volume: 38
  start-page: 1834
  year: 2012
  end-page: 1842
  ident: bib14
  article-title: Association between hyperkalemia at critical care initiation and mortality
  publication-title: Intensive Care Med
  contributor:
    fullname: Christopher
– volume: 15
  start-page: 11
  year: 2014
  end-page: 23
  ident: bib3
  article-title: Acute and chronic cardiovascular effects of hyperkalemia: new insights into prevention and clinical management
  publication-title: Rev Cardiovasc Med
  contributor:
    fullname: Bennett-Guerrero
– volume: 351
  start-page: 543
  year: 2004
  end-page: 551
  ident: bib7
  article-title: Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study
  publication-title: N Engl J Med
  contributor:
    fullname: Lee
– volume: 347
  start-page: 93
  year: 2014
  end-page: 100
  ident: bib10
  article-title: Management of hyperkalemia in hospitalized patients
  publication-title: Am J Med Sci
  contributor:
    fullname: Doran
– volume: 372
  start-page: 222
  year: 2015
  end-page: 231
  ident: bib21
  article-title: Sodium zirconium cyclosilicate in hyperkalemia
  publication-title: N Engl J Med
  contributor:
    fullname: Lavin
– volume: 112
  start-page: 1362
  year: 2005
  end-page: 1374
  ident: bib12
  article-title: Renovascular hypertension and ischemic nephropathy
  publication-title: Circulation
  contributor:
    fullname: Textor
– volume: 119
  start-page: 141
  year: 2009
  end-page: 147
  ident: bib8
  article-title: Iatrogenic hyperkalemia as a serious problem in therapy of cardiovascular diseases in elderly patients
  publication-title: Pol Arch Med Wewn
  contributor:
    fullname: Janowska-Molenda
– volume: 56
  start-page: 20d
  year: 1985
  end-page: 23d
  ident: bib15
  article-title: Malignant arrhythmia in relation to serum potassium in acute myocardial infarction
  publication-title: Am J Cardiol
  contributor:
    fullname: Nordrehaug
– volume: 5
  start-page: 1544
  year: 2010
  end-page: 1551
  ident: bib5
  article-title: Beta-blockers, trimethoprim-sulfamethoxazole, and the risk of hyperkalemia requiring hospitalization in the elderly: a nested case-control study
  publication-title: Clin J Am Soc Nephrol
  contributor:
    fullname: Gomes
– volume: 372
  start-page: 211
  year: 2015
  end-page: 221
  ident: bib19
  article-title: Patiromer in patients with kidney disease and hyperkalemia receiving RAAS inhibitors
  publication-title: N Engl J Med
  contributor:
    fullname: Bushinsky
– volume: 109
  start-page: 307
  year: 2000
  end-page: 314
  ident: bib9
  article-title: Drug-induced hyperkalemia: old culprits and new offenders
  publication-title: Am J Med
  contributor:
    fullname: Perazella
– volume: 64
  start-page: 811
  year: 2014
  end-page: 819
  ident: bib13
  article-title: Blood transfusion during acute myocardial infarction: association with mortality and variability across hospitals
  publication-title: J Am Coll Cardiol
  contributor:
    fullname: Marso
– volume: 16
  start-page: R225
  year: 2012
  ident: bib2
  article-title: Severe hyperkalemia requiring hospitalization: predictors of mortality
  publication-title: Crit Care
  contributor:
    fullname: Jeon
– volume: 104
  start-page: 1985
  year: 2001
  end-page: 1991
  ident: bib16
  article-title: Renal considerations in angiotensin converting enzyme inhibitor therapy: a statement for healthcare professionals from the Council on the Kidney in Cardiovascular Disease and the Council for High Blood Pressure Research of the American Heart Association
  publication-title: Circulation
  contributor:
    fullname: Wilcox
– volume: 312
  start-page: 2223
  year: 2014
  end-page: 2233
  ident: bib20
  article-title: Effect of sodium zirconium cyclosilicate on potassium lowering for 28 days among outpatients with hyperkalemia: the HARMONIZE randomized clinical trial
  publication-title: JAMA
  contributor:
    fullname: Lavin
– volume: 15
  start-page: 11
  year: 2014
  ident: 10.1016/j.amjmed.2016.03.008_bib3
  article-title: Acute and chronic cardiovascular effects of hyperkalemia: new insights into prevention and clinical management
  publication-title: Rev Cardiovasc Med
  doi: 10.3909/ricm0727
  contributor:
    fullname: McCullough
– volume: 64
  start-page: 811
  year: 2014
  ident: 10.1016/j.amjmed.2016.03.008_bib13
  article-title: Blood transfusion during acute myocardial infarction: association with mortality and variability across hospitals
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2014.05.040
  contributor:
    fullname: Salisbury
– volume: 118
  start-page: 1643
  year: 2008
  ident: 10.1016/j.amjmed.2016.03.008_bib6
  article-title: Serum potassium and clinical outcomes in the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS)
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.108.778811
  contributor:
    fullname: Pitt
– volume: 312
  start-page: 2223
  year: 2014
  ident: 10.1016/j.amjmed.2016.03.008_bib20
  article-title: Effect of sodium zirconium cyclosilicate on potassium lowering for 28 days among outpatients with hyperkalemia: the HARMONIZE randomized clinical trial
  publication-title: JAMA
  doi: 10.1001/jama.2014.15688
  contributor:
    fullname: Kosiborod
– volume: 91
  start-page: 177
  year: 2008
  ident: 10.1016/j.amjmed.2016.03.008_bib18
  article-title: Hyperkalemia during spironolactone use in patients with decompensated heart failure
  publication-title: Arq Bras Cardiol
  doi: 10.1590/S0066-782X2008000300004
  contributor:
    fullname: Lima
– volume: 119
  start-page: 141
  year: 2009
  ident: 10.1016/j.amjmed.2016.03.008_bib8
  article-title: Iatrogenic hyperkalemia as a serious problem in therapy of cardiovascular diseases in elderly patients
  publication-title: Pol Arch Med Wewn
  contributor:
    fullname: Wozakowska-Kaplon
– volume: 102
  start-page: 557
  year: 1989
  ident: 10.1016/j.amjmed.2016.03.008_bib17
  article-title: Hyperkalaemia in patients in hospital
  publication-title: N Z Med J
  contributor:
    fullname: Moore
– volume: 372
  start-page: 211
  year: 2015
  ident: 10.1016/j.amjmed.2016.03.008_bib19
  article-title: Patiromer in patients with kidney disease and hyperkalemia receiving RAAS inhibitors
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1410853
  contributor:
    fullname: Weir
– volume: 112
  start-page: 1362
  year: 2005
  ident: 10.1016/j.amjmed.2016.03.008_bib12
  article-title: Renovascular hypertension and ischemic nephropathy
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.104.492348
  contributor:
    fullname: Garovic
– volume: 347
  start-page: 93
  year: 2014
  ident: 10.1016/j.amjmed.2016.03.008_bib10
  article-title: Management of hyperkalemia in hospitalized patients
  publication-title: Am J Med Sci
  doi: 10.1097/MAJ.0b013e318279b105
  contributor:
    fullname: Fordjour
– ident: 10.1016/j.amjmed.2016.03.008_bib4
– volume: 16
  start-page: R225
  year: 2012
  ident: 10.1016/j.amjmed.2016.03.008_bib2
  article-title: Severe hyperkalemia requiring hospitalization: predictors of mortality
  publication-title: Crit Care
  doi: 10.1186/cc11872
  contributor:
    fullname: An
– volume: 109
  start-page: 307
  year: 2000
  ident: 10.1016/j.amjmed.2016.03.008_bib9
  article-title: Drug-induced hyperkalemia: old culprits and new offenders
  publication-title: Am J Med
  doi: 10.1016/S0002-9343(00)00496-4
  contributor:
    fullname: Perazella
– volume: 38
  start-page: 1834
  year: 2012
  ident: 10.1016/j.amjmed.2016.03.008_bib14
  article-title: Association between hyperkalemia at critical care initiation and mortality
  publication-title: Intensive Care Med
  doi: 10.1007/s00134-012-2636-7
  contributor:
    fullname: McMahon
– volume: 21
  start-page: 261
  year: 2005
  ident: 10.1016/j.amjmed.2016.03.008_bib11
  article-title: Contrast-induced nephropathy
  publication-title: Crit Care Clin
  doi: 10.1016/j.ccc.2004.12.003
  contributor:
    fullname: McCullough
– volume: 56
  start-page: 20d
  year: 1985
  ident: 10.1016/j.amjmed.2016.03.008_bib15
  article-title: Malignant arrhythmia in relation to serum potassium in acute myocardial infarction
  publication-title: Am J Cardiol
  doi: 10.1016/0002-9149(85)91110-5
  contributor:
    fullname: Nordrehaug
– volume: 104
  start-page: 1985
  year: 2001
  ident: 10.1016/j.amjmed.2016.03.008_bib16
  article-title: Renal considerations in angiotensin converting enzyme inhibitor therapy: a statement for healthcare professionals from the Council on the Kidney in Cardiovascular Disease and the Council for High Blood Pressure Research of the American Heart Association
  publication-title: Circulation
  doi: 10.1161/hc4101.096153
  contributor:
    fullname: Schoolwerth
– volume: 372
  start-page: 222
  year: 2015
  ident: 10.1016/j.amjmed.2016.03.008_bib21
  article-title: Sodium zirconium cyclosilicate in hyperkalemia
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1411487
  contributor:
    fullname: Packham
– volume: 307
  start-page: 157
  year: 2012
  ident: 10.1016/j.amjmed.2016.03.008_bib1
  article-title: Serum potassium levels and mortality in acute myocardial infarction
  publication-title: JAMA
  doi: 10.1001/jama.2011.1967
  contributor:
    fullname: Goyal
– volume: 351
  start-page: 543
  year: 2004
  ident: 10.1016/j.amjmed.2016.03.008_bib7
  article-title: Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa040135
  contributor:
    fullname: Juurlink
– volume: 5
  start-page: 1544
  year: 2010
  ident: 10.1016/j.amjmed.2016.03.008_bib5
  article-title: Beta-blockers, trimethoprim-sulfamethoxazole, and the risk of hyperkalemia requiring hospitalization in the elderly: a nested case-control study
  publication-title: Clin J Am Soc Nephrol
  doi: 10.2215/CJN.01970310
  contributor:
    fullname: Weir
SSID ssj0000956
Score 2.4031572
Snippet Abstract Background Hyperkalemia is common and potentially dangerous in hospitalized patients; its contemporary prevalence and prognostic importance after...
Hyperkalemia is common and potentially dangerous in hospitalized patients; its contemporary prevalence and prognostic importance after acute myocardial...
Grodzinsky et al determine the contemporary prevalence and prognostic importance of hyperkalemia after acute myocardial infarction. Of 38,689 patients with...
BACKGROUNDHyperkalemia is common and potentially dangerous in hospitalized patients; its contemporary prevalence and prognostic importance after acute...
SourceID pubmedcentral
proquest
crossref
pubmed
elsevier
SourceType Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 858
SubjectTerms Acute myocardial infarction
Aged
Dialysis
Female
Heart attacks
Hemodialysis
Hospital Mortality
Humans
Hyperkalemia - epidemiology
Hyperkalemia - etiology
Hyperkalemia - mortality
Hyperkalemia - therapy
Hyperkalemia prevalence
Internal Medicine
Male
Mortality
Myocardial Infarction - complications
Myocardial Infarction - mortality
Potassium
Prevalence
Prognosis
Registries
Renal Dialysis
Risk Factors
United States - epidemiology
Title Prevalence and Prognosis of Hyperkalemia in Patients with Acute Myocardial Infarction
URI https://www.clinicalkey.es/playcontent/1-s2.0-S0002934316303175
https://dx.doi.org/10.1016/j.amjmed.2016.03.008
https://www.ncbi.nlm.nih.gov/pubmed/27060233
https://www.proquest.com/docview/1818704053
https://search.proquest.com/docview/1807080716
https://pubmed.ncbi.nlm.nih.gov/PMC5031155
Volume 129
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLbKJiFeEHcKAxmJN5TKuSePVRlUVEUTW8XeLMcX0aKlqBek7WfwizknTpx0ZQL20KhKTpzE5_M5x_a5EPI201j0KCs8aQrmgUWcegWIPS_SKUBEqkxkGCg8_ZyMZ9Gn8_i81_vV8VraboqBvPpjXMltuArngK8YJfsfnHWNwgn4D_yFI3AYjv_EY8y_JKqoocbpH93mbIaRMUwwV9_h6sVc4KLGiU2gWkezDSX6B0wvQZOtlM23YQDyjkuLFkRuT6eTZOL6jvxHEMNXWAP70jpJ2kCz6Xu76i0dGa5VVBQFlu3-2SEan7ZEa1ueCnRAvavVWTiXI5gzY2Uh51z8bjjotHMy7q5j-InzouvK5jy0SZv2BLtdY1gMxMUCPhFd8pI6OW2ryJrN--PRxPfWwYB5p9gotglWJ0NLaZfYzoL4OuCM75HeIYcBCC-QmofDyZevk1a_51VNYPe-TUBm5TW4_343GTz7E5rrfrkdQ-fsAblfz1Do0MLtIenp8hG5O605_pjMWtRRQB11qKNLQ7uoo_OSNqijiDpaoY62qKMt6p6Q2Yfjs9HYq4tzeDKOko0XKeEXkVYq98PC-EozYwzu-zMQChJHqTJ5IqSJWFrkMgwDIYSSCYt0FgoVhU_JQbks9XNCwzjRYDkWGRjDUWxA72XCKKkCpQ1Lpe4Tr-lB_sPmYOGNc-KC2x7n2OOchRx6vE_Sppt5E18MGlGv63Gy5jfxvHtnbYFay5IDDv_yzKOGn7x9DFjDIPJAz_XJG3cZ5DduyolSL7dIA0oXfn7SJ88s-91HBpjaKgjh7nQHGI4Ac8PvXinn36oc8THDNFrxi1t3xUtyrx2lR-Rgs9rqV2B_b4rX9YD4DTFZ13Q
link.rule.ids 230,315,783,787,888,27936,27937
linkProvider Library Specific Holdings
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Prevalence+and+Prognosis+of+Hyperkalemia+in+Patients+with+Acute+Myocardial+Infarction&rft.jtitle=The+American+journal+of+medicine&rft.au=Grodzinsky%2C+Anna%2C+MD%2C+MSc&rft.au=Goyal%2C+Abhinav%2C+MD%2C+MHS&rft.au=Gosch%2C+Kensey%2C+MS&rft.au=McCullough%2C+Peter+A.%2C+MD%2C+MPH&rft.date=2016-08-01&rft.issn=0002-9343&rft_id=info:doi/10.1016%2Fj.amjmed.2016.03.008&rft.externalDBID=ECK1-s2.0-S0002934316303175&rft.externalDocID=1_s2_0_S0002934316303175
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0002-9343&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0002-9343&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0002-9343&client=summon